Knowing the risk factors of age-related macular degeneration (AMD) and consulting an ophthalmologist or optometrist can help ...

Oculomics, or the study of the retina using AI, emerged as a groundbreaking field with potential to detect things like ...

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...

And given that few things give away our age quite like our hands, it’s not a bad idea to invest in products that are made to ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 ...

Retinal thickness could be an early indicator of diseases such as Type 2 diabetes and dementia, according to study by a team of Australian-led international researchers. Researchers led by the Walter ...

Atsena Therapeutics ("Atsena”) is a clinical-stage gene therapy company developing best-in-class treatments for the reversal or prevention of blindness from inherited retinal diseases. The company's ...

SYDNEY: Retinal thickness could be an early indicator of diseases such as Type 2 diabetes and dementia, according to study by a team of Australian-led international researchers on Wednesday.